Literature DB >> 15960569

Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000.

Giuseppe Guaiana1, Margherita Andretta, Letizia Corbari, Mersia Mirandola, Adriano Sorio, Barbara D'Avanzo, Corrado Barbui.   

Abstract

OBJECTIVE: This study investigated the impact of the increasing consumption of selective serotonin reuptake inhibitors (SSRIs) and newer anti-depressants on the following public health indicators: (1) suicide rates, (2) proportion of completed suicides by poisoning with solid or liquid substances, and (3) hospital admissions for depression and proportion of admissions for depression that were first admissions.
METHOD: Data collected by IMS Health on antidepressants dispensed in Italy from 1983 to 2000 were obtained from the Italian Ministry of Health, while data on suicide deaths from 1955 to 2000 were obtained from the Italian National Institute of Statistics.
RESULTS: In Italy from 1983 to 2000, the use of tricyclic antidepressants remained substantially stable, and the use of SSRIs and newer agents dramatically increased. In contrast, suicide rates for males decreased from 1955 to 1974 and subsequently increased, reaching a peak in 1985 and then declining. In females, suicide rates remained substantially stable until 1978. A subsequent increase occurred up to 1985, followed by a steady decline. Suicide by poisoning using solids or liquids dropped by nearly 50% from 1986 to 2000. Admissions to the hospital for depression showed an erratic pattern; however, no decline was observed. No change was observed in the rate of first admissions for depression.
CONCLUSION: Despite a reduction in suicides by poisoning using solids or liquids, the analysis of long-term trends in suicide did not suggest that increases in antidepressant prescribing lie behind recent reductions in population suicides. Furthermore, in Italy, newer antidepressants had no impact on the total number of admissions for depression or on the proportion of all admissions that were first admissions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960569     DOI: 10.4088/jcp.v66n0612

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  18 in total

Review 1.  Mirtazapine versus other antidepressive agents for depression.

Authors:  Norio Watanabe; Ichiro M Omori; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

Authors:  Atsuo Nakagawa; Michael F Grunebaum; Steven P Ellis; Maria A Oquendo; Haruo Kashima; Robert D Gibbons; J John Mann
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

3.  Factors influencing variation in prescribing of antidepressants by general practices in Scotland.

Authors:  Jill Morrison; Mary-Jane Anderson; Matt Sutton; Rosalia Munoz-Arroyo; Sara McDonald; Margaret Maxwell; Andrew Power; Michael Smith; Philip Wilson
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

4.  Getting through the quicksand of the relationship between drugs and suicide.

Authors:  Corrado Barbui
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

5.  Paroxetine versus other anti-depressive agents for depression.

Authors:  Andrea Cipriani; Toshi A Furukawa; Antonio Veronese; Norio Watanabe; Rachel Churchill; Hugh McGuire; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2007

6.  Venlafaxine versus other anti-depressive agents for depression.

Authors:  Andrea Cipriani; Alessandra Signoretti; Toshi A Furukawa; Rachel Churchill; Silva Tomelleri; Ichiro M Omori; Hugh McGuire; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2007

7.  Short-term effects of the 2008 Great Recession on the health of the Italian population: an ecological study.

Authors:  Giorgio Mattei; Silvia Ferrari; Luca Pingani; Marco Rigatelli
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-21       Impact factor: 4.328

Review 8.  Fluvoxamine versus other anti-depressive agents for depression.

Authors:  Ichiro M Omori; Norio Watanabe; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Hugh McGuire; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

9.  'A coal face option': GPs' perspectives on the rise in antidepressant prescribing.

Authors:  Sara Macdonald; Jill Morrison; Margaret Maxwell; Rosalia Munoz-Arroyo; Andrew Power; Michael Smith; Matt Sutton; Philip Wilson
Journal:  Br J Gen Pract       Date:  2009-09       Impact factor: 5.386

Review 10.  Escitalopram versus other antidepressive agents for depression.

Authors:  Andrea Cipriani; Claudio Santilli; Toshi A Furukawa; Alessandra Signoretti; Atsuo Nakagawa; Hugh McGuire; Rachel Churchill; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.